Multicenter, Single-arm, Two Stage Phase II Trial of RAD001 (Everolimus) With Imatinib in Imatinib-resistant Patients With Progressive GIST.
Phase of Trial: Phase IV
Latest Information Update: 21 Nov 2016
At a glance
- Drugs Everolimus (Primary) ; Imatinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- Acronyms Radix
- 24 Apr 2012 Planned End Date 1 Dec 2012 added as reported by ClinicalTrials.gov.
- 22 Jan 2010 Status changed from discontinued to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Jan 2010 Actual end date (May 2009) added as reported by ClinicalTrials.gov.